Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Use of electronic medical records and biomarkers to manage risk and resource efficiencies
Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland..
Univ Liverpool Liverpool Sch Trop Med, Clin Sci, Liverpool, Merseyside, England.;Royal Liverpool Hosp, Resp Med, Liverpool, Merseyside, England..
Resp Effectiveness Grp, Cambridge, England..
Resp Effectiveness Grp, Cambridge, England.;Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland.;Observat & Pragmat Res Inst, Singapore, Singapore..
Show others and affiliations
2017 (English)In: EUROPEAN CLINICAL RESPIRATORY JOURNAL, ISSN 2001-8525, Vol. 4, 1-12 p., 1293386Article in journal (Refereed) Published
Abstract [en]

The migration from paper to electronic medical records (EMRs) was motivated by the administrative need to record, retrieve and process increasing amounts of clinical data in the 1980s. In the intervening period, there has been growing recognition of the potential of such records for achieving care efficiencies, informing clinical decision making and real-life research. EMRs can be used to characterise patient groups, management approaches and differential outcomes. Characterisation can also help with identification of potential biomarkers for future risk determination and likely treatment response. The future heralds even greater opportunities through integration of clinical records and a range of technology-based solutions within a more complete electronic health record (EHR). Through application of algorithms based on identified risk predictors and disease determinants, clinical records could also be used to enable risk stratification of patients to optimise targeted interventions, conserving resources to achieve individual patient and system-wide benefit. In this review, we reflect on the evolution of the EMR and EHR and discuss current and emerging opportunities, particularly with respect to biomarkers and targeting of innovative biologic interventions. We also consider some of the critical issues associated with realising the potential of the EHR as a clinical aid and research tool in an age of emerging technologies.

Place, publisher, year, edition, pages
TAYLOR & FRANCIS LTD , 2017. Vol. 4, 1-12 p., 1293386
Keyword [en]
Electronic medical record (EMR), electronic health record (EHR), database, asthma, biomarker, primary care, CDSS, big data
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:uu:diva-320217DOI: 10.1080/20018525.2017.1293386ISI: 000397597800001OAI: oai:DiVA.org:uu-320217DiVA: diva2:1088918
Available from: 2017-04-18 Created: 2017-04-18 Last updated: 2017-04-18Bibliographically approved

Open Access in DiVA

fulltext(1857 kB)66 downloads
File information
File name FULLTEXT01.pdfFile size 1857 kBChecksum SHA-512
b506b809c6553d0f0a6394b7186b91e4d0c60a478b6f840e67f393246c5b7c30b641e2ab03425047374d8104862ee7638ef72d97219535258992381077c58ee5
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Ställberg, BjörnLisspers, Karin
By organisation
Family Medicine and Preventive Medicine
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar
Total: 66 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 283 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf